Home > Insider Trading > Filing (0001654954-20-000267)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1540159	Edesa Biotech Inc.	EDSA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053878	K Lorin Johnson	C/O Edesa Biotech, Inc. 100 Spy Court Markham A6 L3R5H6		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-01-08	8,524	$4.11	8,524	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Common Share Warrants (Right to Buy)	Acquisiton	2020-01-08	6,393	$0.00	6,393	$4.80
Common Shares	Common Share Warrants (Right to Buy)	Acquisiton	2020-01-08	4,262	$0.00	4,262	$4.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,393	2020-07-08	2023-07-08	No	4	P	Direct
4,262	2020-07-08	2020-11-08	No	4	P	Direct

Footnotes

The reported securities are included within 8,524 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.